Cancer Research Solutions
Cancer research breakthroughs begin within insight
Over the last few decades, innovations in cancer research have advanced at a rapid pace, with new targeted treatments and immunotherapies showing great promise. However, due to the heterogenous nature of the disease, therapy resistance – whether intrinsic or acquired – remains a huge challenge. Research that unlocks the molecular mechanisms behind cancer evolution may be a key to future drug discovery and, ultimately, may provide personalized combinational therapies to individuals, creating the potential for improved outcomes.
Explore the complexities of cancer hallmarks
Cancer hallmarks initially outlined over a decade ago describe the mechanisms acquired during tumor development and form the basis for ongoing research. We’re committed to helping you explore and unravel the complexities of interconnected hallmarks and developing those research findings into future targets.
With a diverse range of cancer research tools and solutions to accelerate your research, we help scientists study all aspects of cancer, from genomics to precision medicine research and beyond.
The next big cancer breakthrough will begin with research. And that research can begin with you.
For research use only. Not for use in diagnostic procedures.
Explore our cancer research solutions
Cancer genomics
Cancer genomics aims to understand the genetic basis by which tumors proliferate and evolve under selection by its microenvironment, the immune system, and therapeutic intervention. Identifying the genetic and epigenetic changes at the root of cancer has improved our understanding of its biology and may lead to new methods of detecting and treating disease.
Epigenetic research reagents
The epigenetics’ field revolutionized the understanding of heredity.
NGSワークフロー
The library preparation workflow is the process of getting DNA or RNA ready for Next Generation Sequencing (NGS).
CRISPR Technologies
CRISPR-Cas9 genome engineering technologies hold great promise for understanding diseases and for the development of life saving treatments.
Single-Cell Sequencing
Single-cell analysis identifies information often overlooked by bulk approaches. We offer solutions for key steps in the single-cell sequencing workflow.
Cancer cell biology
Cancer cell biology investigates the underlying differences between normal cells and cancer cells and elucidates basic mechanisms that drive the development and behavior of tumors. Understanding this biology, and the fundamental processes governing transformation, is critical for identifying future molecular targets for therapeutic or preventive intervention.
Targeted Protein Degradation
Protein homeostasis in the cellular environment is achieved through the ubiquitin-proteasome system (UPS) and the autophagy-lysosomal system (ALS).
GPCR research reagents
G protein-coupled receptors (GPCRs) are the largest family of membrane proteins and the most studied targets in drug discovery. They relay extracellular signals by triggering intracellular pathways through coupling with G proteins and arrestins.
Protein-protein interaction research reagents
The interactions and binding of proteins are implicated in a large number of biological processes. The need for efficient, highly sensitive assays to study large protein interactions is increasingly important.
Protein kinase research reagents
The human kinome comprises 518 protein kinases and 20 lipid kinases.
Cell Counting and Image Cytometry
Revvity offers a leading portfolio of automated cell counters, image cytometry systems, and cell counting reagents and consumables.
Immuno-oncology
Immuno-oncology (I-O) is an especially exciting area of research because it harnesses the body’s immune system to fight cancers. However, to develop new ways to improve immune cell activity, you need a deep understanding of the complex relationship among tumor biology, tumor microenvironment, and the immune system.
Our wide range of tools helps support and advance your I-O research, redefining and developing tailored, life-changing immunotherapies to fight cancer.
Protein kinase research reagents
The human kinome comprises 518 protein kinases and 20 lipid kinases.
Cytokine Research Reagents
Cytokines regulate several physiological and pathological roles including innate immunity, acquired immunity, and many inflammatory responses.
Multiomics and TotalSeq Reagents by BioLegend
Multiomics provides unparalleled protein and genetic analysis. Explore how our TotalSeq™ reagents can be integrated into your existing workflows and expand your capabilities.
In vivo イメージング
生物学的プロセスと疾患の進行を追跡、モニタリング、可視化することは、生物学の理解を深めるだけでなく、開発プロセスの早い段階で潜在的な新薬候補の有効性を評価する上で極めて重要です。
Cellular Imaging & Analysis
With more than a decade of experience in this field, Revvity provides a portfolio of cellular Imaging products
Tumor Microenvironment
Imaging tumors within their microenvironments provides insights into complex interactions between cancer cells and surrounding immune cells, fibroblasts, signaling molecules, and extracellular matrices. Recent advances in tumor biology reveal these interactions control tumor growth and the development of metastasis, providing future targets for therapeutic intervention.
In vivo イメージング
生物学的プロセスと疾患の進行を追跡、モニタリング、可視化することは、生物学の理解を深めるだけでなく、開発プロセスの早い段階で潜在的な新薬候補の有効性を評価する上で極めて重要です。
Multiomics and TotalSeq Reagents by BioLegend
Multiomics provides unparalleled protein and genetic analysis. Explore how our TotalSeq™ reagents can be integrated into your existing workflows and expand your capabilities.
Precision medicine research
Every cancer is unique, from their genetic makeup to their microenvironment. The future of individually tailored therapy research relies on developing our understanding of both the underlying genetics and functional responses of cancers to stay one step ahead.
Our complementary approaches allow you to screen an individuals’ molecular profiles to enable you to get the clarity you need in your research to identify the right target at the right time.
Functional Testing
No two cancers are the same —from their genetic makeup to their microenvironment —so the treatment needs to match the uniqueness.
ctDNA Workflows
Analyzing circulating tumor DNA (ctDNA) offers a non-invasive, dynamic window into the body’s physiological state and its use as a biomarker is gaining rapidly.
Exosome/cfRNA Analysis
Extracellular vesicles are membrane-bound compartments which are being increasingly recognized as important players in cell-to-cell communication.
Signals ソフトウエア
初期段階の研究から後期段階の開発まで、Revvity Signals ソフトウェアは、製薬/バイオテクノロジーや材料、スペシャリティケミカル、臨床科学など、さまざまな業界で働く科学者の方々にご活用いただけます。
Explore our solutions
Featured resources
Featured blogs
